Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.05B |
| 3 |
Alibaba
BABA
|
+$905M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$371M |
| 5 |
Kroger
KR
|
+$307M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.33B |
| 3 |
Microsoft
MSFT
|
+$961M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$803M |
| 5 |
Amazon
AMZN
|
+$740M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.03% |
| 2 | Healthcare | 9.27% |
| 3 | Financials | 9.12% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Communication Services | 6.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Phibro Animal Health
PAHC
$1.39B
| $7.7M | ﹤0.01% |
292,960
-66,422
| -18% | -$1.65M |
|
2427
John Wiley & Sons Class A
WLY
$2.61B
| $7.7M | ﹤0.01% |
197,337
-34,055
| -15% | -$1.3M |
|
2428
CALL
Ferrari
RACE
$72.9B
| $7.7M | ﹤0.01% |
45,000
-40,000
| -47% | -$6.45M |
|
2429
AnaptysBio
ANAB
$1.73B
| $7.69M | ﹤0.01% |
344,166
+237,809
| +224% | +$4.35M |
|
|
GMS
2430
DELISTED
GMS Inc
GMS
| $7.66M | ﹤0.01% |
311,288
-146,324
| -32% | -$2.79M |
|
|
ILPT
2431
Industrial Logistics Properties Trust
ILPT
$595M
| $7.65M | ﹤0.01% |
372,266
-250,373
| -40% | -$4.6M |
|
2432
Ascendis Pharma A/S
ASND
$16.3B
| $7.64M | ﹤0.01% |
51,633
+7,191
| +16% | +$987K |
|
2433
DNOW Inc
DNOW
$2.97B
| $7.64M | ﹤0.01% |
884,829
-77,356
| -8% | -$531K |
|
|
MAGN
2434
Magnera Corp
MAGN
$444M
| $7.62M | ﹤0.01% |
36,496
-6,960
| -16% | -$1.32M |
|
2435
Sunstone Hotel Investors
SHO
$2.03B
| $7.61M | ﹤0.01% |
933,743
+114,563
| +14% | +$995K |
|
2436
CALL
Illumina
ILMN
$28.8B
| $7.59M | ﹤0.01% |
21,074
+13,672
| +185% | +$4.4M |
|
2437
Blackbaud
BLKB
$2.05B
| $7.58M | ﹤0.01% |
132,830
-16,129
| -11% | -$887K |
|
|
EQC
2438
DELISTED
Equity Commonwealth
EQC
| $7.58M | ﹤0.01% |
235,282
-106,356
| -31% | -$3.51M |
|
|
AXNX
2439
DELISTED
Axonics, Inc. Common Stock
AXNX
| $7.56M | ﹤0.01% |
215,404
-238,531
| -53% | -$8.22M |
|
2440
Arvinas
ARVN
$587M
| $7.54M | ﹤0.01% |
224,941
+1,863
| +0.8% | +$79.1K |
|
2441
PUT
Merck
MRK
$335B
| $7.54M | ﹤0.01% |
102,180
-284,742
| -74% | -$21.4M |
|
2442
PUT
Bristol-Myers Squibb
BMY
$130B
| $7.54M | ﹤0.01% |
128,200
+30,200
| +31% | +$1.81M |
|
2443
Workiva
WK
$3.84B
| $7.53M | ﹤0.01% |
140,673
+26,499
| +23% | +$1.09M |
|
2444
Veracyte
VCYT
$3.32B
| $7.52M | ﹤0.01% |
290,528
-499,772
| -63% | -$12.5M |
|
2445
Universal Electronics
UEIC
$67.9M
| $7.52M | ﹤0.01% |
160,557
-30,398
| -16% | -$1.28M |
|
2446
Westlake Chemical Partners
WLKP
$765M
| $7.51M | ﹤0.01% |
396,808
-52,797
| -12% | -$961K |
|
2447
MBIA
MBI
$264M
| $7.49M | ﹤0.01% |
1,033,093
-426,808
| -29% | -$3.1M |
|
2448
The Ensign Group
ENSG
$10.6B
| $7.47M | ﹤0.01% |
178,526
-155,536
| -47% | -$6.17M |
|
2449
Virgin Galactic
SPCE
$503M
| $7.47M | ﹤0.01% |
+22,864
| New | +$7.51M |
|
|
AERI
2450
DELISTED
Aerie Pharmaceuticals
AERI
| $7.46M | ﹤0.01% |
505,753
+314,691
| +165% | +$4.66M |
|
Similar funds
Goldman Sachs's Q2 2020 Portfolio in Review
As of Q2 2020, Goldman Sachs held 5,697 positions worth $329B, up 16% from $284B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs withdrew a net $19.5B in Q2 2020, closing 535 positions and reducing 2,401 holdings. Its most notable exit was Allergan plc, an estimated $1.33B position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Goldman Sachs MarketBeta US Equity ETF worth $209M.
- Goldman Sachs's largest Q2 2020 buy was Goldman Sachs MarketBeta US Equity ETF: 4,910,076 shares worth $209M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $2.58B increase.
- Goldman Sachs's biggest Q2 2020 reduction was Apple, cutting an estimated $1.38B.
- Goldman Sachs fully exited Allergan plc in Q2 2020, selling an estimated $1.33B.
- Goldman Sachs's ten largest holdings make up 19% of its $329B portfolio in Q2 2020.
- Goldman Sachs opened 507 new positions and closed 535 in Q2 2020.
- Goldman Sachs's portfolio value rose 16% quarter-over-quarter to $329B.
Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.